Molly Cornbleet
Senior Director, Corporate Communications
Veracyte
Bio:
Molly Cornbleet leads Public Relations at Veracyte, a leader in cancer diagnostics, where she is responsible for global communications got the company’s precision oncology portfolio. With more than 20 years of experience in healthcare and biotech communications, she specializes in translating complex science into compelling stories that drive awareness, influence stakeholders and ultimately improve patient care. Most recently, Molly led the integrated communications strategy surrounding the landmark OPTIMA clinical trial and the U.S. launch of the Prosigna® Breast Risk of Recurrence test, securing global media attention around one of the year's most significant oncology data announcements.